Gene · 8174
Papers1,829
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,829
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Novel Pharmacological Treatment Options of Steroid-Refractory Graft-versus-Host Disease. | Adv Hematol | 2023 | 38094101 | PubTator, text mining | PubMed |
| Microbiota: A key factor affecting and regulating the efficacy of immunotherapy. | Clin Transl Med | 2023 | 38082435 | PubTator, text mining | PubMed |
| Pediatric-type follicular lymphoma in a Crohn's disease patient receiving anti-α4β7-integrin therapy: A case report. | World J Gastroenterol | 2023 | 38074918 | PubTator, text mining | PubMed |
| Gut-lung axis: role of the gut microbiota in non-small cell lung cancer immunotherapy. | Front Oncol | 2023 | 38074650 | PubTator, text mining | PubMed |
| The V2 domain of HIV gp120 mimics an interaction between CD4 and integrin ⍺4β7. | PLoS Pathog | 2023 | 38064524 | PubTator, text mining | PubMed |
| Cardiovascular implications of inflammatory bowel disease: An updated review. | World J Cardiol | 2023 | 38058397 | PubTator, text mining | PubMed |
| An overview of recent treatment options for primary sclerosing cholangitis. | Ann Gastroenterol | 2023 | 38023975 | PubTator, text mining | PubMed |
| The Efficacy and Safety of Biologic Drugs in the Treatment of Moderate-Severe Crohn's Disease: A Systematic Review. | Pharmaceuticals (Basel) | 2023 | 38004446 | PubTator, text mining | PubMed |
| The Force-Dependent Mechanism of an Integrin α4β7-MAdCAM-1 Interaction. | Int J Mol Sci | 2023 | 38003252 | PubTator, text mining | PubMed |
| Evolutionary origin and structural ligand mimicry by the inserted domain of alpha-integrin proteins. | bioRxiv | 2023 | 37986796 | PubTator, text mining | PubMed |
| Association of CD4-positive cell infiltration with response to vedolizumab in patients with ulcerative colitis. | Sci Rep | 2023 | 37985889 | PubTator, text mining | PubMed |
| Cutaneous manifestations of inflammatory bowel disease: basic characteristics, therapy, and potential pathophysiological associations. | Front Immunol | 2023 | 37954590 | PubTator, text mining | PubMed |
Pyoderma gangrenosum in ulcerative colitis patient treated with vedolizumab: adsorptive granulocyte/monocyte apheresis as a new therapeutic option refractory cases - a case report and literature review. | Ther Adv Chronic Dis | 2023 | 37928629 | PubTator, text mining | PubMed |
| Immune-mediated cholangiopathies in children: the need to better understand the pathophysiology for finding the future possible treatment targets. | Front Immunol | 2023 | 37928553 | PubTator, text mining | PubMed |
| E-selectin-mediated rapid NLRP3 inflammasome activation regulates S100A8/S100A9 release from neutrophils via transient gasdermin D pore formation. | Nat Immunol | 2023 | 37903858 | PubTator, text mining | PubMed |
| An obesogenic diet increases atherosclerosis through promoting microbiota dysbiosis-induced gut lymphocyte trafficking into the periphery. | Cell Rep | 2023 | 37897726 | PubTator, text mining | PubMed |
| Current and Novel Therapies for Eosinophilic Gastrointestinal Diseases. | Int J Mol Sci | 2023 | 37894846 | PubTator, text mining | PubMed |
| Effects of Golimumab and Ustekinumab on Circulating Dendritic Cell Migratory Capacity in Inflammatory Bowel Disease. | Biomedicines | 2023 | 37893204 | PubTator, text mining | PubMed |
| Efficacy of Switching to Adalimumab for Maintenance of Remission Following Induction Therapy with Tacrolimus in Patients with Ulcerative Colitis. | J Clin Med | 2023 | 37892837 | PubTator, text mining | PubMed |
| Colitis-associated carcinogenesis: crosstalk between tumors, immune cells and gut microbiota. | Cell Biosci | 2023 | 37875976 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8174/papers?page=6